Olema Pharmaceuticals Statistics
Total Valuation
OLMA has a market cap or net worth of $996.20 million. The enterprise value is $490.00 million.
| Market Cap | 996.20M |
| Enterprise Value | 490.00M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OLMA has 87.35 million shares outstanding. The number of shares has increased by 37.98% in one year.
| Current Share Class | 87.35M |
| Shares Outstanding | 87.35M |
| Shares Change (YoY) | +37.98% |
| Shares Change (QoQ) | +12.57% |
| Owned by Insiders (%) | 2.72% |
| Owned by Institutions (%) | 92.80% |
| Float | 64.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.06 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.88, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.88 |
| Quick Ratio | 10.79 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.86% and return on invested capital (ROIC) is -27.59%.
| Return on Equity (ROE) | -42.86% |
| Return on Assets (ROA) | -25.50% |
| Return on Invested Capital (ROIC) | -27.59% |
| Return on Capital Employed (ROCE) | -39.67% |
| Weighted Average Cost of Capital (WACC) | 15.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.35M |
| Employee Count | 137 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +157.37% in the last 52 weeks. The beta is 2.01, so OLMA's price volatility has been higher than the market average.
| Beta (5Y) | 2.01 |
| 52-Week Price Change | +157.37% |
| 50-Day Moving Average | 11.96 |
| 200-Day Moving Average | 17.42 |
| Relative Strength Index (RSI) | 45.34 |
| Average Volume (20 Days) | 1,807,333 |
Short Selling Information
The latest short interest is 14.03 million, so 16.07% of the outstanding shares have been sold short.
| Short Interest | 14.03M |
| Short Previous Month | 12.84M |
| Short % of Shares Out | 16.07% |
| Short % of Float | 21.86% |
| Short Ratio (days to cover) | 6.81 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -191.81M |
| Pretax Income | -185.15M |
| Net Income | -185.15M |
| EBITDA | -191.33M |
| EBIT | -191.81M |
| Earnings Per Share (EPS) | -$2.03 |
Balance Sheet
The company has $505.35 million in cash and $3.96 million in debt, with a net cash position of $501.39 million or $5.74 per share.
| Cash & Cash Equivalents | 505.35M |
| Total Debt | 3.96M |
| Net Cash | 501.39M |
| Net Cash Per Share | $5.74 |
| Equity (Book Value) | 480.48M |
| Book Value Per Share | 5.50 |
| Working Capital | 466.06M |
Cash Flow
| Operating Cash Flow | -148.72M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 481,000 |
| Net Borrowing | 3.00M |
| Free Cash Flow | -148.72M |
| FCF Per Share | -$1.70 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OLMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.98% |
| Shareholder Yield | -37.98% |
| Earnings Yield | -18.68% |
| FCF Yield | -15.00% |
Analyst Forecast
The average price target for OLMA is $40.70, which is 256.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.70 |
| Price Target Difference | 256.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |